Investment analysts at StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report released on Friday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Stock Down 0.3 %
Shares of Veradigm stock opened at $9.40 on Friday. Veradigm has a 52 week low of $5.01 and a 52 week high of $13.62. The stock’s fifty day moving average is $9.52 and its two-hundred day moving average is $9.14.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the stock. Innealta Capital LLC purchased a new stake in Veradigm in the 2nd quarter valued at about $38,000. Vanguard Group Inc. increased its position in shares of Veradigm by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after acquiring an additional 95,291 shares during the period. Finally, Tyro Capital Management LLC bought a new stake in shares of Veradigm during the first quarter valued at approximately $9,055,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Most Volatile Stocks, What Investors Need to Know
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Earnings Per Share Calculator: How to Calculate EPS
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.